Spots Global Cancer Trial Database for Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures
Official Title: Safety and Efficacy of Dexmedetomidine vs Ketamine vs Midazolam Combined With Propofol in Gastrointestinal Procedures for Cancer Patients
Study ID: NCT04597268
Conditions
Study Description
Brief Summary: This study aims to assess the safety and efficacy of dexmedetomidine versus ketamine versus midazolam combined with propofol in cancer patients undergoing gastrointestinal endoscopic procedures.
Detailed Description: Comparison between using intravenous (IV) propofol combined with either IV dexmedetomidine or IV ketamine or IV midazolam; to study the effect of their combination on level of sedation and hemodynamic stability on adult patients scheduled for gastrointestinal endoscopic procedures.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Walaa Y Elsabeeny, Cairo, , Egypt
Contact Details
Name: Walaa Y Elsabeeny, MD
Affiliation: Lecturer
Role: PRINCIPAL_INVESTIGATOR
Name: Nahla Y Shehab, MD
Affiliation: Lecturer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
